Browse > Article
http://dx.doi.org/10.5713/ajas.2007.856

Development and Characterization of a Specific Anti-Caveolin-1 Antibody for Caveolin-1 Functional Study in Human, Goat and Mouse  

Ke, Meng-Wei (Department of Animal Science and Technology, National Taiwan University)
Jiang, Yan-Nian (Department of Animal Science and Technology, National Taiwan University)
Li, Yi-Hung (Department of Animal Science and Technology, National Taiwan University)
Tseng, Ting-Yu (Department of Animal Science and Technology, National Taiwan University)
Kung, Ming-Shung (Department of Animal Science and Technology, National Taiwan University)
Huang, Chiun-Sheng (Department of Surgery, National Taiwan University Hospital and National Taiwan University of College of Medicine)
Cheng, Winston Teng-Kuei (Department of Animal Science and Technology, National Taiwan University)
Hsu, Jih-Tay (Department of Animal Science and Technology, National Taiwan University)
Ju, Yu-Ten (Department of Animal Science and Technology, National Taiwan University)
Publication Information
Asian-Australasian Journal of Animal Sciences / v.20, no.6, 2007 , pp. 856-865 More about this Journal
Abstract
Caveolin-1 of the caveolin family of proteins regulates mammary gland development and has been shown to play a contradictory role in breast tumor progression. A specific anti-Caveolin-1 antibody will be useful for functional study of Caveolin-1 in different tissues. In this study, we generated a rabbit polyclonal antibody that specifically recognizes the N-terminal amino acids 50-65 of Caveolin-1. This polyclonal antibody specifically reacted with Caveolin-1 extracted from cells of different species, including human epithelial A431 cells, goat primary mammary epithelial cells and mice fibroblast NIH 3T3 cells, by Western blotting. Endogenous Caveolin-1 protein expressing in cells and normal human tissues was detected by this polyclonal antibody using immunocytofluorescent and immunohistochemical staining, respectively. Furthermore, an apparent decrease in Caveolin-1 expression in tumorous breast and colon tissues was detected by this polyclonal antibody. In conclusion, we have identified amino acids 50-65 of Caveolin-1, which contains an epitope that is specific to Caveolin-1 and is conserved in the human, goat and mouse. In future, this anti-Caveolin-1 antibody can be used to examine the progression of breast and colon cancers and to study functions of Caveolin-1 in human, goat and mouse cells.
Keywords
Caveolin-1; Peptide Antibody; Breast Cancer; Goat; Cancer Marker;
Citations & Related Records

Times Cited By Web Of Science : 0  (Related Records In Web of Science)
Times Cited By SCOPUS : 0
연도 인용수 순위
  • Reference
1 Barnes, D. M., W. H. Harris, P. Smith, R. R. Millis and R. D. Rubens. 1996. Immunohistochemical determination of oestrogen receptor: comparison of different methods of assessment of staining and correlation with clinical outcome of breast cancer patients. Br. J. Cancer 74:1445-1451.   DOI   ScienceOn
2 Bush, W. S., G. Ihrke, J. M. Robinson and A. K. Kenworthy. 2006. Antibody-specific detection of caveolin-1 in subapical compartments of MDCK cells. Histochem. Cell Biol. 126:27-34.   DOI   ScienceOn
3 Kerr, J., J. A. Leary, T. Hurst, Y. C. Shih, T. M. Antalis, M. Friedlander, E. Crawford, S. K. Khoo, B. Ward and G. Chenevix-Trench. 1996. Allelic loss on chromosome 7q in ovarian adenocarcinomas: two critical regions and a rearrangement of the PLANH1 locus. Oncogene 13:1815-1818.
4 Lavie, Y., G. Fiucci and M. Liscovitch. 1998. Up-regulation of caveolae and caveolar constituents in multidrug-resistant cancer cells. J. Biol. Chem. 273:32380-32383.   DOI   ScienceOn
5 Okamoto, T., A. Schlegel, P. E. Scherer and M. P. Lisanti. 1998. Caveolins, a family of scaffolding proteins for organizing "reassembled signaling complexes" at the plasma membrane. J. Biol. Chem. 273:5419-5422.   DOI   ScienceOn
6 Pantschenko, A. G., J. Woodcock-Mitchell, S. L. Bushmich and T. J. Yang. 2000. Establishment and characterization of a caprine mammary epithelial cell line (CMEC). In vitro Cell Dev. Biol. Anim. 36:26-37.   DOI   ScienceOn
7 Park, D. S., H. Lee, P. G. Frank, B. Razani, A. V. Nguyen, A. F. Parlow, R. G. Russell, J. Hulit, R. G. Pestell and M. P. Lisanti. 2002. Caveolin-1-deficient mice show accelerated mammary gland development during pregnancy, premature lactation, and hyperactivation of the Jak-2/STAT5a signaling cascade. Mol. Biol. Cell 13:3416-3430.   DOI   ScienceOn
8 Rothberg, K. G., J. E. Heuser, W. C. Donzell, Y. S. Ying, J. R. Glenney and R. G. Anderson. 1992. Caveolin, a protein component of caveolae membrane coats. Cell 68:673-682.   DOI   ScienceOn
9 Shridhar, V., Q. C. Sun, O. J. Miller, G. P. Kalemkerian, J. Petros and D. I. Smith. 1997. Loss of heterozygosity on the long arm of human chromosome 7 in sporadic renal cell carcinomas. Oncogene 15:2727-2733.   DOI   ScienceOn
10 Zenklusen, J. C., J. C. Thompson, A. J. Klein-Szanto and C. J. Conti. 1995. Frequent loss of heterozygosity in human primary squamous cell and colon carcinomas at 7q31.1: evidence for a broad range tumor suppressor gene. Cancer Res. 55:1347-1350.
11 Nestl, A., O. D. Von Stein, K. Zatloukal, W. G. Thies, P. Herrlich, M. Hofmann and J. P. Sleeman. 2001. Gene expression patterns associated with the metastatic phenotype in rodent and human tumors. Cancer Res. 61:1569-1577.
12 Wiechen, K., L. Diatchenko, A. Agoulnik, K. M. Scharff, H. Schober, K. Arlt, B. Zhumabayeva, P. D. Siebert, M. Dietel, R. Schafer and C. Sers. 2001. Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene. Am. J. Pathol. 159:1635-1643.   DOI   ScienceOn
13 Koleske, A. J., D. Baltimore and M. P. Lisanti. 1995. Reduction of caveolin and caveolae in oncogenically transformed cells. Proc. Natl. Acad. Sci. USA. 92:1381-1385.   DOI   ScienceOn
14 Li, S., J. Couet and M. P. Lisanti. 1996. Src tyrosine kinases, G subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. J. Biol. Chem. 271:29182-29190.   DOI   ScienceOn
15 Lee, H., D. S. Park, B. Razani, R. G. Russell, R. G. Pestell and M. P. Lisanti. 2002. Caveolin-1 mutations (P132L and null) and the pathogenesis of breast cancer. Am. J. Pathol. 161:1357-1369.   DOI   ScienceOn
16 Li, J. T., A. H. Wang, P. Chen, H. B. Li, C. S. Zhang and L. X. Du. 2006. Relationship between the polymorphisms of 5' regulation region of prolactin gene and milk traits in Chinese Holstein dairy cows. Asian-Aust. J. Anim. Sci. 19:459-462.   DOI
17 Razani, B. and M. P. Lisanti. 2001. Caveolin-deficient mice: insights into caveolar function and human disease. J. Clin. Invest. 108:1553-1561.   DOI
18 Yang, G., L. D. Truong, T. L. Timme, C. Ren, T. M. Wheeler, S. H. Park, Y. Nasu, C. H. Bangma, M. W. Kattan, P. T. Scardino and T. C. Thompson. 1998. Elevated expression of caveolin is associated with prostate and breast cancer. Clin. Cancer Res. 4:1873-1880.
19 Capozza, F., T. M. Williams, W. Schubert, S. McClain, B. Bouzahzah, F. Sotgia and M. P. Lisanti. 2003. Absence of caveolin-1 sensitizes mouse skin to carcinogen-induced epidermal hyperplasia and tumor formation. Am. J. Pathol. 162:2029-2039.   DOI   ScienceOn
20 Couet, J. M., M. Sargiacomo and M. P. Lisanti. 1997. Interaction of a receptor tyrosine kinase, EGF-R, with caveolins: caveolin-binding negatively regulates tyrosine and serine/threonine kinase activities. J. Biol. Chem. 272:30429-30438.   DOI   ScienceOn
21 Zenklusen, J. C., J. C. Thompson, P. Troncoso, J. Kagan and C. J. Conti. 1994b. Loss of heterozygosity in human primary prostate carcinomas: a possible tumor suppressor gene at 7q31.1. Cancer Res. 54:6370-6373.
22 Engelman, J. A., C. C. Wykoff, S. Yasuhara, K. S. Song, T. Okamoto and M. P. Lisanti. 1997. Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth. J. Biol. Chem. 272:16374-16381.   DOI   ScienceOn
23 Seol, M. B., J. J. Bong and M. Baik. 2006. Involvement of Cathepsin D in apoptosis of mammary epithelial cells. Asian-Aust. J. Anim. Sci. 19:1100-1105   DOI
24 Cui, J., L. R. Rohr, G. Swanson, V. O. Speights, T. Maxwell and A. R. Brothman. 2001. Hypermethylation of the caveolin-1 gene promoter in prostate cancer. Prostate 46:249-256.   DOI   ScienceOn
25 Sager, R., S. Sheng, A. Anisowicz, G. Sotiropoulou, Z. Zou, G. Stenman, K. Swisshelm, Z. Chen, M. J. Hendrix, P. Pemberton, K. Rafidi and K. Ryan. 1994. RNA genetics of breast cancer: maspin as a paradigm. Cold Spring Harb. Symp. Quant. Biol. 59:537-546.   DOI   ScienceOn
26 Ju, H., R. Zou, V. J. Venema and R. C. Venema. 1997. Direct interaction of endothelial nitric-oxide synthase and caveolin-1 inhibits synthase activity. J. Biol. Chem. 272:18522-18525.   DOI   ScienceOn
27 Chen, S. T., S. Y. Lin, K. T. Yeh, S. J. Kuo, W. L. Chan, Y. P. Chu and J. G. Chang. 2004. Mutational, epigenetic and expressional analyses of caveolin-1 gene in breast cancers. Int. J. Mol. Med. 14:577-582.
28 Engelman, J. A., R. J. Lee, A. Karnezis, D. J. Bearss, M. Webster, P. Siegel, W. J. Muller, J. J. Windle, R. G. Pestell and M. P. Lisanti. 1998. Reciprocal regulation of neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo. J. Biol. Chem. 273:20448-20455.   DOI   ScienceOn
29 Kato, K., Y. Hida, M. Miyamoto, H. Hashida, T. Shinohara, T. Itoh, S. Okushiba, S. Kondo and H. Katoh. 2002. Overexpression of caveolin-1 in esophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage. Cancer 94:929-933.   DOI   ScienceOn
30 Jenkins, R., S. Takahashi, K. Delacey, E. Bergstralh and M. Lieber. 1998. Prognostic significance of allelic imbalance of chromosome arms 7q, 8p, 16q, and 18q in stage T3N0M0 prostate cancer. Genes Chromosomes Cancer 21:131-143.   DOI   ScienceOn
31 Lin, S. Y., K. T. Yeh, W. T. Chen, H. C. Chen, S. T. Chen and J. G. Chang. 2004. Promoter CpG methylation of caveolin-1 in sporadic colorectal cancer. Anticancer Res. 24:1645-1650.
32 Song, K. S., S. Li, T. Okamoto, L. A. Quilliam, M. Sargiacomo and M. P. Lisanti. 1996a. Co-purification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. J. Biol. Chem. 271:9690-9697.   DOI
33 Zhang, W., B. Razani, Y. Altschuler, B. Bouzahzah, K. E. Mostov, R. G. Pestell and M. P. Lisanti. 1998. Caveolin-1 inhibits epidermal growth factor-stimulated lamellipod extension and cell migration in metastatic mammary adenocarcinoma cells (MTLn3). J. Biol. Chem. 275:20717-20725.   DOI   ScienceOn
34 Park, D. S., H. Lee, C. Riedel, J. Hulit, P. E. Scherer, R. G. Pestell and M. P. Lisanti. 2001. Prolactin negatively regulates caveolin-1 gene expression in the mammary gland during lactation, via a Ras-dependent mechanism. J. Biol. Chem. 276:48389-48397.   DOI
35 Ho, C. C., P. H. Huang, H. Y. Huang, Y. H. Chen, P. C. Yang and S. M. Hsu. 2002. Up-regulated caveolin-1 accentuates the metastasis capability of lung adenocarcinoma by inducing filopodia formation. Am. J. Pathol. 161:1647-1656.   DOI   ScienceOn
36 Sunaga, N., K. Miyajima, M. Suzuki, M. Sato, M. A. White, R. D. Ramirez, J. W. Shay, A. F. Gazdar and J. D. Minna. 2004. Different roles for caveolin-1 in the development of non-small cell lung cancer versus small cell lung cancer. Cancer Res. 64:4277-4285.   DOI   ScienceOn
37 Song, K. S., P. E. Scherer, Z. Tang, T. Okamoto, S. Li, M. Chafel, C. Chu, D. S. Kohtz and M. P. Lisanti. 1996b. Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. J. Biol. Chem. 271:15160-15165.   DOI   ScienceOn
38 Wikman, H., J. Seppanen, V. K. Sarhadi, E. Kettunen, K. Salmenkivi, E. Kuosma, K. Vainio-Siukola, B. Nagy, A. Karjalainen, T. Sioris, J. Salo, J. Hollmen, S. Knuutila and S. Anttila. 2004. Caveolins as tumor markers in lung cancer detected by combined use of cDNA and tissue microarrays. J. Pathol. 203:584-593.   DOI   ScienceOn
39 Zenklusen, J. C., I. Bieche, R. Lidereau and C. J. Conti. 1994a. $(C-A)_{n}$ microsatellite repeat D7S522 is the most commonly deleted region in human primary breast cancer. Proc. Natl. Acad. Sci. USA. 91:12155-12158.   DOI   ScienceOn
40 Smart, E. J., G. A. Graf, M. A. McNiven, W. C. Sessa, J. A. Engelman, P. E. Scherer, T. Okamoto and M. P. Lisanti. 1999. Caveolins, liquid-ordered domains, and signal transduction. Mol. Cell. Biol. 19:7289-7304.   DOI
41 Krajewska, W. M. and I. Maslowska. 2004. Caveolins: structure and function in signal transduction. Cell. Mol. Biol. Lett. 9:195-220.
42 Sargiacomo, M., P. E. Scherer, Z. Tang, E. Kubler, K. S. Song, M. C. Sanders and M. P. Lisanti. 1995. Oligomeric structure of caveolin: implications for caveolae membrane organization. Proc. Natl. Acad. Sci. USA. 92:9407-9411   DOI   ScienceOn
43 Wary, K. K., A. Mariotti, C. Zurzolo and F. G. Giancotti. 1998. A requirement of caveolin-1 and associated kinase Fyn in integrin signaling and anchorage-dependent cell growth. Cell 94:625-634.   DOI   ScienceOn
44 Joo, H. J., D. K. Oh, Y. S. Kim, K. B. Lee and S. J. Kim. 2004. Increased expression of caveolin-1 and microvessel density correlates with metastasis and poor prognosis in clear cell renal cell carcinoma. BJU Int. 93:291-296.   DOI   ScienceOn
45 Engelman, J. A., X. L. Zhang and M. P. Lisanti. 1999. Sequence and detailed organization of the human caveolin-1 and -2 genes located near the D7S522 locus (7q31.1). FEBS Lett. 448:221-230.   DOI   ScienceOn
46 Sloan, E. K., K. L. Stanley and R. L. Anderson. 2004. Caveolin-1 inhibits breast cancer growth and metastasis. Oncogene 23:7893-7897.   DOI   ScienceOn